The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 12, 2020
Filed:
Jan. 03, 2017
Applicants:
Centre National DE LA Recherche Scientifique-cnrs, Paris, FR;
Centre Hospitalier Regional Universitaire DE Lille, Lille, FR;
Inventors:
Nicolas Pottier, Lomme, FR;
Bernard Mari, Nice, FR;
Brice Marcet, Mougins, FR;
Pascal Barbry, Nice, FR;
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris, FR;
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE, Lille, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12Q 1/6883 (2018.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 9/007 (2013.01); A61K 9/12 (2013.01); C12Q 1/6883 (2013.01); C12N 2310/11 (2013.01); C12N 2310/111 (2013.01); C12N 2310/14 (2013.01); C12N 2320/32 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01);
Abstract
The present invention relates to the use of the miRNA expression profile, particularly of miR-199a-5p, and the target genes regulated thereby for the diagnosis, prognosis and use of miR-199a-5p inhibitors for treating fibroproliferative disorders.